FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095386 [Registered on: 24/09/2025] Trial Registered Prospectively
Last Modified On: 24/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of nordic walking on lungs, fitness, and life quality in people with COPD 
Scientific Title of Study   EFFECT OF NORDIC WALKING ON PULMONARY FUNCTION, FUNCTIONAL CAPACITY AND QUALITY OF LIFE AMONG COPD INDIVIDUALS 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anamika Rajpoot 
Designation  PG Student 
Affiliation  Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation 
Address  Cardiothoracic and Pulmonary Disorder Lab Ground Floor, Department of Physiotherapy Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation
Mullana,Ambala Haryana
Ambala
HARYANA
133203
India 
Phone  8091765704  
Fax  -  
Email  anamika15102001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Mandeep K Jangra  
Designation  Associate Professor 
Affiliation  Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation 
Address  Cardiothoracic and Pulmonary Disorder Lab Ground Floor, Department of Physiotherapy Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation
Department of Physiotherapy Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation
Ambala
HARYANA
133203
India 
Phone  9813397708  
Fax  -  
Email  mandeep.jangra@mmumullana.org  
 
Details of Contact Person
Public Query
 
Name  Dr Mandeep K Jangra 
Designation  Associate Professor 
Affiliation  Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation 
Address  Cardiothoracic and Pulmonary Disorder Lab Ground Floor, Department of Physiotherapy Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation
Ground Floor, Department of Physiotherapy Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation
Ambala
HARYANA
133203
India 
Phone  9813397708  
Fax  -  
Email  mandeep.jangra@mmumullana.org  
 
Source of Monetary or Material Support  
Anamika Rajpoot Department of Physiotherapy, Maharishi Markandeshwar Institute of Physiotherapy and Rehabiliation , Mullana Ambala Haryana 133203 
 
Primary Sponsor  
Name  Anamika Rajpoot 
Address  Maharishi Markandeshwar Institue of Physiotherapy and Rehabilitation 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Anamika Rajpoot  Dr. Anamika Rajpoot  Maharishi Markandeshwar Institue of Physiotherapy and Rehabilitation
Ambala
HARYANA 
8091765704

anamika15102001@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Maharishi Markandeshwar Institute of Medical Sciences and Research Mullana, Ambala. Communication of Decision of the Ethics Committee (IEC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J449||Chronic obstructive pulmonary disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nordic Walking  Patient will recieve interention for 6 weeks. In each week 3 sessions will be given. Every session will be of 40 minutes which consist 10 minutes of warm up, 20 minutes of nordic walking and 10 minutes of cool down. 
Comparator Agent  Pulmonary Rehabilitaion  Patients in control group will receive purse lip breathing exercise, ACBT, inspiratory muscle training for 6 weeks. In each week there will be 3 sessions.  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1. GOLD stage II or IV (moderate to very severe COPD)
2. Able to walk independently without walking aids 
 
ExclusionCriteria 
Details  1. Active smokers
2. Diagnosis other respiratory condition
3. Cardiac arrythmias
4. Disease that decreases exercise capacity (anemia, electrolyte imbalance)
5. Gait disorders
6. Acute MI in the last 6 months
7. Participation in any other exercise program in past 6 months
8. Resting heart rate of more than 120
9. Systolic blood pressure of more than 180 mm Hg, and Diastolic blood pressure of more than 100 mm Hg 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Pulmonary Function (FEV1; FVC; FEV1/FVC)
 
Baseline and after 6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1. Functional Capacity
2. Quality of Life 
Baseline and after 6 weeks 
 
Target Sample Size   Total Sample Size="12"
Sample Size from India="12" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  22/09/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This randomization controlled trial will evaluate the effectiveness of Nordic walking on pulmonary function, functional capacity and quality of life among COPD individuals. Participants will be randomly allocated to nordic walking group or control group.   
Close